Zamudio, Spain
At Syngoi we produce linear, covalently locked, minimal DNA constructs containing only the DNA sequence of interest. We have developed and patented cell-free production methods to synthesise oDNA containing natural and/or non-natural nucleotides as adaptors. This scalable process allows manufacturing under GMP conditions, cost-effective, high-fidelity, significantly faster than pDNA production and customisable.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Syngoi Technologies on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
